Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) shares dropped 2.8% during mid-day trading on Tuesday . The company traded as low as $0.66 and last traded at $0.68. Approximately 65,906 shares were traded during trading, a decline of 1% from the average daily volume of 66,374 shares. The stock had previously closed at $0.70.
Shuttle Pharmaceuticals Trading Down 2.8 %
The stock’s 50 day moving average is $0.78.
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Featured Articles
- Five stocks we like better than Shuttle Pharmaceuticals
- 3 Tickers Leading a Meme Stock Revival
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Transportation Stocks Investing
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
